Results 31 to 40 of about 2,995,113 (384)

Guidelines for clinical diagnosis and treatment of urinary tract infection in kidney transplant recipients in China [PDF]

open access: yesXin yixue
Urinary tract infection is the most common infectious complication after kidney transplantation. To further reduce the incidence of urinary tract infection after kidney transplantation, improve the diagnosis and treatment level of urinary tract infection
Branch of Organ Transplantation of Chinese Medical Association
doaj   +1 more source

Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. [PDF]

open access: yes, 2011
Technological advances in molecular and in silico research have enabled significant progress towards personalized transplantation medicine. It is now possible to conduct comprehensive biomarker development studies of transplant organ pathologies ...
Khatri, Purvesh   +3 more
core   +3 more sources

Bioenergetics Consequences of Mitochondrial Transplantation in Cardiomyocytes. [PDF]

open access: yes, 2020
Background Mitochondrial transplantation has been recently explored for treatment of very ill cardiac patients. However, little is known about the intracellular consequences of mitochondrial transplantation.
Ali Pour, Paria   +2 more
core  

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

open access: yesGastroenterology, 2015
BACKGROUND & AIMS Nonalcoholic steatohepatitis (NASH) has been predicted to become the leading indication for liver transplantation (LT) in the United States.
R. Wong   +6 more
semanticscholar   +1 more source

Improvement of clinical and laboratory parameters in a canine with idiopathic chronic hepatitis after transplantation of allogeneic mesenchymal cells derived from bone marrow - case report [PDF]

open access: yesArquivo Brasileiro de Medicina Veterinária e Zootecnia
Chronic hepatitis (CH) is characterized by the replacement of hepatocytes for fibrotic tissue after injury, and treatment is not curative. Stem cell therapy has shown potential to reduce liver fibrosis.
L.G. Santos   +4 more
doaj   +1 more source

Indwelling Pleural Catheters in Hepatic Hydrothorax: A Single-Center Series of Outcomes and Complications [PDF]

open access: yes, 2018
Background Treatment of hepatic hydrothorax (HH) generally involves sodium restriction, diuretics, and serial thoracentesis. In more advanced cases, transjugular intrahepatic portosystemic shunt and liver transplantation may be required.
Bosslet, Gabriel   +3 more
core   +1 more source

Extracellular Vesicles Derived From Adult and Fetal Bone Marrow Mesenchymal Stromal Cells Differentially Promote ex vivo Expansion of Hematopoietic Stem and Progenitor Cells

open access: yesFrontiers in Bioengineering and Biotechnology, 2021
Recently, we and others have illustrated that extracellular vesicles (EVs) have the potential to support hematopoietic stem and progenitor cell (HSPC) expansion; however, the mechanism and processes responsible for the intercellular communication by EVs ...
Corina A. Ghebes   +14 more
doaj   +1 more source

Chimerism after organ transplantation [PDF]

open access: yes, 1997
Recent evidence suggests that passenger leukocytes migrate after organ transplantation and produce persistent chimerism, which is essential for sustained survival of the allograft.
Demetris, AJ   +6 more
core   +1 more source

A Strategy to Simultaneously Cure Type 1 Diabetes and Diabetic Nephropathy by Transplant of Composite Islet-Kidney Grafts

open access: yesFrontiers in Endocrinology, 2021
In recent years islet cell transplant has proven itself to be a viable clinical option for a select group of diabetic patients. Graft loss after transplant however continues to hinder the long-term success of the procedure.
Thomas Pomposelli   +6 more
doaj   +1 more source

Ex vivo anchored PD‐L1 functionally prevent in vivo renal allograft rejection

open access: yesBioengineering & Translational Medicine, 2022
Organ transplantation is the optimal treatment for patients with end‐stage diseases. T cell activation is a major contributing factor toward the trigger of rejection. Induction therapy with T cell depleting agent is a common option but increases the risk
Zihuan Luo   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy